SELAMAWIT GEBREZGHI: Open Payments
NPI 1912175787 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 38 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $361 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $756 |
| Neurelis, Inc. | 1 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $32 |
| PFIZER INC. | 1 | $26 |
| SK Life Science, Inc. | 1 | $15 |
Products named: QULIPTA, UBRELVY, BOTOX, VALTOCO, INGREZZA, AUSTEDO XR, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
